Literature DB >> 10492104

The value of sonography in early pregnancy for the detection of fetal abnormalities in an unselected population.

B J Whitlow1, I K Chatzipapas, M L Lazanakis, R A Kadir, D L Economides.   

Abstract

OBJECTIVE: To determine the value of early pregnancy sonography in detecting fetal abnormalities in an unselected obstetric population. DESIGN Prospective cross-sectional study. All women initially underwent transabdominal sonography and when the anatomical survey was considered to be incomplete, transvaginal sonography was also performed (20.1%). Nuchal translucency was measured and karyotyping was performed as appropriate.
SETTING: University Department of Obstetrics and Gynaecology. PARTICIPANTS: 6634 sequential unselected women (mean maternal age 29.9 years, range 13-50; mean gestational age 12+4 weeks, range 11+0-14+6), carrying 6443 live fetuses participated in this study. MAIN OUTCOME MEASURE: Detection rate of fetal anomalies and the associated cost per case detected in early pregnancy.
RESULTS: The incidence of anomalous fetuses was 1.4% (92/6443) including 43 chromosomal abnormalities. The detection rate for structural abnormalities was 59.0% (37/63, 95% CI 46.5-72.4) and the specificity was 99.9% in early pregnancy. When the first and second trimester scans were combined, the detection for structural abnormalities was 81.0% (51/63, 95% CI 67.7-89.2). Seventy-eight percent (31/40) of chromosomal abnormalities (excluding three cases of XXY) were diagnosed at 11-14 weeks, either because of a nuchal translucency greater than or equal to the 99th centile for gestational age (43%; 17/40, 95% CI 27.4-60.4), or due to the presence of structural abnormalities (35%; 14/40, 95% CI 21.2-52.8). Sixty-five percent (15/23) of cases of trisomy 21 were also diagnosed either because of having a nuchal translucency greater than or equal to the 99th centile (57.0%; 13/23) or due to the presence of a structural abnormality (9.0%; 2/23). Overall, the detection rate of structurally abnormal fetuses was 59% (37/63) in early pregnancy and 81% in combination with the second trimester scan. The cost per abnormality diagnosed in early pregnancy is estimated to be pound sterling 6258 per structurally abnormal fetus, pound sterling 7470 per chromosomal abnormality and pound sterling 4453 per anomalous fetus.
CONCLUSION: The majority of fetal structural and chromosomal abnormalities can be detected by sonographic screening at 11-14 weeks, but the second trimester scan should not be abandoned.

Entities:  

Mesh:

Year:  1999        PMID: 10492104     DOI: 10.1111/j.1471-0528.1999.tb08432.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  12 in total

Review 1.  Evolution of fetal ultrasonography.

Authors:  F E Avni; T Cos; M Cassart; A Massez; C Donner; K Ismaili; M Hall
Journal:  Eur Radiol       Date:  2006-05-30       Impact factor: 5.315

2.  The Performance of First-Trimester Anatomy Scan: A Decision Analysis.

Authors:  Lorie M Harper; S Lindsay Wood; Sheri M Jenkins; John Owen; Joseph R Biggio
Journal:  Am J Perinatol       Date:  2016-04-22       Impact factor: 1.862

3.  First-Trimester Detection of Surface Abnormalities: A Comparison of 2- and 3-Dimensional Ultrasound and 3-Dimensional Virtual Reality Ultrasound.

Authors:  Leonie Baken; Melek Rousian; Anton H J Koning; Gouke J Bonsel; Alex J Eggink; Jérôme M J Cornette; Ernst M Schoonderwaldt; Margreet Husen-Ebbinge; Katinka K Teunissen; Peter J van der Spek; Eric A P Steegers; Niek Exalto
Journal:  Reprod Sci       Date:  2014-01-18       Impact factor: 3.060

Review 4.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 5.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 6.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

7.  Early Detection of Fetal Malformation, a Long Distance Yet to Cover! Present Status and Potential of First Trimester Ultrasonography in Detection of Fetal Congenital Malformation in a Developing Country: Experience at a Tertiary Care Centre in India.

Authors:  Namrata Kashyap; Mandakini Pradhan; Neeta Singh; Sangeeta Yadav
Journal:  J Pregnancy       Date:  2015-11-23

Review 8.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

Review 9.  Urine tests for Down's syndrome screening.

Authors:  S Kate Alldred; Boliang Guo; Yemisi Takwoingi; Mary Pennant; Susanna Wisniewski; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10

10.  The contribution and the importance of modern ultrasound techniques in the diagnosis of major structural abnormalities in the first trimester - case reports.

Authors:  R Dragusin; M Florea; D Iliescu; Smarandita Cotarcea; Stefania Tudorache; Liliana Novac; N Cernea
Journal:  Curr Health Sci J       Date:  2012-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.